SPCs In Europe – Overview, Latest Developments And Practice Points – Patent

On Aug 4, 2026

J A Kemp LLP

J A Kemp is a leading firm of European Patent and Trade Mark Attorneys. We combine independent thinking with collective excellence in all that we do.

The technical and legal knowledge that we apply to the protection of our clients’ patents is outstanding in its breadth and depth. With around 100 science and technology graduates in the firm, including 50 PhDs, no area of science or technology is outside our scope. Our Patent Attorneys have collective in-depth expertise in patent law and procedure in every country of the world.

The team of professionals who advise our clients on trade mark and design matters have backgrounds in major international law firms and hold qualifications as Chartered UK Trade Mark Attorneys, Solicitors and European Trade Mark Professional Representatives. Dedicated to this specialist area of intellectual property protection, the team has the expertise and resources to protect trade marks and designs in any market worldwide.

Supplementary Protection Certificates are a vital tool for extending protection for authorised human and veterinary medicinal products. Yet the SPC landscape remains complex, fast-moving and often difficult to navigate.

United States
Intellectual Property

To print this article, all you need is to be registered or login on Mondaq.com.

Article Insights

J A Kemp LLP are most popular:

with readers working within the Aerospace & Defence industries

Although the SPC Regulation sets out only four core requirements for grant, each has generated significant legal debate and repeated referrals to the CJEU. Recent legal and political developments continue to shape how these requirements are interpreted.

In this webinar, J A Kemp’s experienced SPC attorneys provide a practical update on the latest developments affecting SPC strategy in Europe and the UK. Drawing on our extensive experience filing and prosecuting SPCs across multiple jurisdictions, we highlight key issues to consider when preparing and managing patent portfolios to make the most of the SPC system.

The session focuses not only on what has changed, but on what those changes mean in practice for patent drafting, filing strategy, ownership planning and third-party risk.

Topics include:

Recent legal developments affecting SPC strategy

Optimising a patent portfolio for SPC protection

Choosing the right patent for SPC applications

SPC considerations in the UK after Brexit

Political developments in Europe affecting SPCs

Whether you are managing an existing SPC portfolio or planning future protection for medicinal products in Europe, this webinar will offer practical guidance on responding to a changing legal landscape and strengthening your SPC strategy.

J A Kemp LLP acts for clients in the USA, Europe and globally, advising on UK and European patent practice and representing them before the European Patent Office, UKIPO and Unified Patent Court. We have in-depth expertise in a wide range of technologies, including Biotech and Life Sciences, Pharmaceuticals, Software and IT, Chemistry, Electronics and Engineering and many others. See our website to find out more.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Source link